Colorimetric determination of olanzapine via charge-transfer complexation with chloranilic acid  by Adegoke, Olajire A. et al.
Ac
a
P
e
w
C
w
i
r
s
t
t
©
t
K
a
P
h
1
CJournal of Taibah University for Science 10 (2016) 651–663
Available  online  at  www.sciencedirect.com
ScienceDirect
Colorimetric determination of olanzapine via charge-transfer
complexation with chloranilic acid
Olajire A. Adegoke ∗, Olusegun E. Thomas, Stephen N. Emmanuel
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
Received 18 May 2015; received in revised form 9 November 2015; accepted 4 December 2015
Available online 19 December 2015
bstract
The charge-transfer complexation (CTC) formed between olanzapine and chloranilic acid have been studied and used as a sensitive
olorimetric method for the determination of olanzapine.
Evidence for the formation of the CTC between chloranilic acid (CAA) and olanzapine (OLP) was established by spot tests
nd TLC. Method development was carried out through selection of analytical wavelength, optimization and validation studies.
hysicochemical parameters such as energy of transition, transition dipole, oscillator frequency and ionization energies were
stimated and related to the stability of the formed CT band. Thermodynamic properties of the CT band at four temperature levels
ere also estimated and their inter-relationship established.
The reaction was completed at room temperature within 10 min with the evidence of formation of purple-coloured solution with
AA that absorbed maximally at 520 nm. Linearity was obtained in the concentration range of 2–40 g/mL for OLP (r  = 0.9977)
ith a limit of detection of 1.57 g/mL. Estimates of accuracies and precisions gave error values less than 2% for both intra- and
nter-day assessments. The transition energies were of the order of 2.303 eV. The Gibbs energy varied with the temperature and
oom temperature values favoured formation of stable complexes. The thermodynamic studies revealed small positive entropy for
lightly negative enthalpy change.
The method was successfully applied to estimate OLP in tablets and the method was found to be of equivalent accuracy with
he Indian Pharmacopoeia’s HPLC method (p  > 0.05). The method could find application as a rapid and sensitive determination
echnique for olanzapine.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Taibah University. This is an open access article under
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1.  Introduction
Olanzapine (OLP), with chemical name 2-methyl-4-
(4-methyl-1-piperazynyl) 10H-thieno-[2,3-b][1,5]benz-
odiazepine is a thienobenzodiazepine derivative (Fig. 1).
It was first synthesized by Eli-lilly, UK in 1982. Thebehalf of Taibah University. This is an open access article under the
FDA, approved olanzapine sold by Eli-lilly under the
trademark Zyprexa® in late 1996 [1]. Olanzapine is used
in the treatment of mental illness in adults and teenagers
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Fig. 1. Structure of olanzapine.
who are 13 years of age and older. The main purpose
is to treat schizophrenia, a mental illness that causes
unusual thinking, loss of interest in life, and strong emo-
tional changes. It is also used to treat bipolar disorder.
Olanzapine is referred to as “atypical antipsychotic”
because it works by changing the activity of certain nat-
ural substances in the brain. Olanzapine molecule has
a high affinity for two receptors in the brain. It binds
to D2 dopamine receptors and 5H2 serotonin receptor
which are important for maintaining chemical balance
within the brain. When a patient has schizophrenia, these
receptors start malfunctioning and thus creating chemi-
cal imbalances in the brain. Olanzapine’s function is to
prevent these receptors from further functioning by bind-
ing to them in such a way that they stop working. The
polarity of olanzapine molecule allows it to bind strongly
to the protein as it is a polar molecule.
The active substance olanzapine is pale yellow to
yellow crystalline powder. Physico-chemical properties
have been adequately described including solubility and
polymorphism. Olanzapine can exist as five possible
polymorphic forms (I, II, III, IV and V). The control
of polymorphism has been achieved and was found to be
stable during stability studies according to the European
Medicine Agency report [2].
Several methods have been reported for the quantita-
tive estimation of OLP in pure drug, dosage form and in
biological fluids and also when OLP is present in combi-
nation with other drugs. These methods include analysis
in biological fluids and dosage forms using HPLC [3–7],
gas chromatographic methods for assay of olanzapine in
human plasma [8] and in human tissue [9] and titration
in non-aqueous medium [10].
Ranking highest among the methods that have been
previously described are several spectrophotometric
methods for the determination of olanzapine in bulk
drug and in formulations. Chemically, olanzapine is
easily oxidized, a potential property that has beenersity for Science 10 (2016) 651–663
adopted by several researchers for accurate estima-
tion of OLP in dosage forms and bulk drugs. Many
oxidizing agents have been used and sometimes in
combination with chromogenic agents, like dyes to
improve and provide accurate quantitation in the visible
region and to avoid interference from other substances
present in its matrix, which might be prominent if
analyses are carried out in the ultraviolet region of
the electromagnetic spectrum. Some of the reagents
that have been reported include; potassium hexacyano-
ferrate(III) [11], N-bromosuccinide and cerium (IV)
sulphate in an acidic medium [12], oxidation with potas-
sium iodate in sulphuric acid medium [13], iodine
monochloride [14], cerium(IV) sulphate as the oxidi-
metric agent and thiocyanate, tiron, and ferrocyanide
as the colour forming complexing [15], bromocresol
purple and bromo thymol blue [16]. A recent spec-
troscopic method for the determination of olanzapine
includes simultaneous determination of olanzapine when
present with fluoxetine HCl without separating from
each other or the excipients. The developed method
was based on simultaneous equations (Verodt’s method)
[1]. Some procedures involving condensation reactions
for the assay of olanzapine using 1,2-Naphtoquinone-
4-sulphate [17] and p-dimethylaminobenzaldehyde [18]
as a derivatizing reagents have also been recently
described.
Although many of these reported methods are accu-
rate and sensitive, some use sophisticated equipment and
expensive reagents. Some are cumbersome in the sense
that, they require prolonged sample pre-treatment, strict
control of pH and longer reaction times. Each method
however has its own merits but the desire to develop
a readily available, simple and yet accurate method
formed the primary motivation for this work. The sensi-
tive, accurate and simple colorimetric determination of
OLP following charge-transfer complexation with chlo-
ranilic acid is described in this report. To the best of our
knowledge of available literature, this is the first charge-
transfer complexation reaction for the determination of
OLP using chloranilic acid.
2.  Experimental
2.1.  Materials  and  reagents
Olanzapine chemical reference substance was used
for this study. Acetone, ethyl acetate, chloroform,
acetonitrile, ammonium orthophosphate, orthophos-
phoric acid (all Analar reagent grade obtained from
BDH Chemical Ltd, Poole England), chloranilic acid,
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ethanol (HPLC grade) was obtained from Sigma-
ldrich; USA, precoated thin layer plates GF245 0.2 mm.
.2.  Equipment
A UV/VIS spectrophotometer (Unicam aurora, Pye
nicam, UK), Analytical balance H80 (Mettler, UK),
ltrasonic bath (Langford Electronics, UK), Vortex
ixer (Gryphons and George Ltd; Great Britain) were
sed for this study.
.3.  Preparation  of  stock  solutions
A 0.025 g quantity of chloranilic acid (CAA) powder
as weighed into a clean 25 mL volumetric flask and
 mL of acetonitrile was added to dissolve it. The solu-
ion was then made up to volume with acetonitrile to
ake 0.1% (w/v) chloranilic acid solution.
For the drug solution, a 0.025 g quantity of olanzapine
OLP) reference standard was weighed into a volumetric
ask, 5 mL of acetonitrile was added to dissolve it and
he solution was made up to volume with acetonitrile to
ake 0.1% (w/v) of olanzapine stock solution.
.4.  Evidence  of  complex  formation
A 0.5 mL aliquot of CAA stock solution was added
nto two test tubes. 0.1 mL of OLP was added into one
ube and the other tube was used as comparison standard.
he immediate appearance of colour in the reaction tube
as noted and then the respective colours were compared
fter 5 and 20 min reaction time.
Further evidence for complex formation was con-
rmed by thin layer chromatography using the reversed
hase method. Three spots were developed, namely
AA, CAA-OLP complex and OLP alone in acetoni-
rile. The plates were developed in a tank using 2 solvents
ystems of acetonitrile/water (6:4) and methanol/water
6:4). The spotted plates were developed in a tank. The
lates were then removed from the tank and viewed
nder UV light at 254 nm and 365 nm to view the
pots generated from the development. The respective
f (retardation factor) values were calculated.
.5.  Optimization  of  reaction  conditions
The analytical wavelength was selected by overlay-
ng the absorption spectra of OLP, CAA and CAA-OLP
omplex in acetonitrile and recording the spectra on a
V–VIS spectrophotometer from 200 to 700 nm. The
ppearance of a new peak in the visible region for thersity for Science 10 (2016) 651–663 653
complex was noted by inspection and utilized for the
subsequent monitoring of the complex.
The optimal temperature and time required for com-
plex formation were determined using the method of
steepest ascent [19]. All the reactions were carried
out using 0.5 mL CAA with 0.1 mL of OLP and the
absorbance of the resulting solutions were determined
at 520 nm using acetonitrile as diluting solvents. For the
optimization of temperature; 30 ◦C, 50 ◦C, 60 ◦C and
80 ◦C were investigated at two time levels of 5 and
20 min. The temperature corresponding to the optimal
absorbance was noted. For the optimization of time, the
reaction mixtures were allowed to stand at 30 ◦C for 0, 2,
5, 10, 15, 20, 25 and 30 min, respectively. The reaction
mixtures were made up to 5 mL with acetonitrile and the
absorbance readings were determined at 520 nm using
acetonitrile as the blank solvent.
The stoichiometric ratio at which OLP combined with
CAA was determined by using aliquots of 0.1% (w/v)
stock solution of OLP (0, 0.25, 0.40, 0.50, 0.60, 0.75,
0.80 and 1.0 mL) representing different concentrations
of (0, 50, 60, 80, 100, 120, 150, 160 and 200 g/mL)
were prepared in different test tubes and made to 1 mL
with CAA solution. These mixtures represent the mole
ratios of OLP and CAA of 0:1, 1:3, 2:3, 1:1, 3:2, 3:1,
4:1 and 1:0. The absorbance readings were recorded at
520 nm and the maximum absorbance was taken as the
optimal stoichiometric ratio.
2.6.  Validation  studies
Using the optimized procedures, calibrations graphs
were prepared using 0.5 mL of 0.1% (w/v) CAA solu-
tion and respective concentrations of 0, 2, 5, 10, 20,
30, 40 g/mL of OLP. The mixture was vortex mixed
and the reaction carried out at 30 ◦C for 10 min after
which varying volumes of acetonitrile was added to make
5 mL of reaction mixture. The absorbance of each of
the mixtures was then recorded at 520 nm. The calibra-
tion curves were prepared on three successive days using
freshly prepared stock solution on each day. The average
absorbance readings obtained from the determinations
were used to generate the working calibration curve.
The accuracy and repeatability of the new charge-
transfer procedure for OLP were carried out on three
successive days according to current ICH guidelines
[20]. These were determined by using quadruplets of
samples of different concentrations of OLP stock solu-
tion (0.05, 0.075 and 0.15 mL) corresponding to 10, 15
and 30 g/mL which represents low, medium and high
concentrations on the calibration curve. The reaction
mixtures were processed as before and the absorbance
h Univ654 O.A. Adegoke et al. / Journal of Taiba
of each of these reaction mixtures were then recorded at
520 nm using acetonitrile as the blank solvent.
2.7.  Estimation  of  molar  absorptivity  and  formation
constants
The Benesi-Hildebrand plot [21] was constructed
from the calibration graphs to estimate the molar absorp-
tivities and formation constants of the CT complexes
formed between the CAA and OLP. The effects of tem-
perature change on these parameters were studied by
recording the absorbance of the CT band at elevated tem-
peratures and calculating the molar absorptivities and
formation constants from the Benesi-Hildebrand equa-
tion.
2.8.  Assessment  of  physicochemical  parameters  of
the charge-transfer  complex
Some physicochemical properties of the charge-
transfer bands were estimated such as molar transition
energy, oscillator strength, transition dipole, resonance
energy and the ionization potential of the donor species;
in order to establish the stability or otherwise of the
formed complex between OLP and CAA.
2.9.  Thermodynamic  studies
The free energy change, enthalpy of formation and
the entropy associated with the formation of the new CT
complex between CAA and OLP were estimated from
the data obtained at different temperature levels of 30,
50, 60 and 80 ◦C.
2.10.  Dosage  form  analysis
Three different brands of Olanzapine tablets dosage
forms were analyzed. They were Olanza 10, Glenmark
UK and Lanzep 10. The different brands of Olanzap-
ine in tablet forms mentioned above were purchased
from a reputable pharmacy store in Ibadan, Oyo state
in Nigeria. Weight uniformity test was carried out on the
different brands of tablets dosage forms and the assay
of the active ingredients was then carried out based on
the new method for each of the brands using the Indian
Pharmacopoeial HPLC method as reference procedure
[22]. Weight uniformity tests were carried out on each
brand of the tablets. An amount of the powdered tablets
equivalent to 0.025 g of olanzapine was extracted into
25 mL of acetonitrile to make 0.1% (w/v) olanzapine
stock solution.ersity for Science 10 (2016) 651–663
A 0.1 mL of the stock solution equivalent to 20 g/mL
was then transferred into six test tubes for each brand.
0.5 mL of 0.1% (w/v) chloranilic acid was added to each
of the test tubes. The reaction was allowed to proceed
for 10 min at 30 ◦C after which acetonitrile was added to
stop the reaction and also to make the reaction mixture
up to 5 mL. The absorbance of the respective reaction
mixture was recorded at 520 nm using acetonitrile as the
blank solvent.
The official method of analysis utilized for olanzap-
ine tablets was HPLC as stipulated in the 2007 edition
of the Indian Pharmacopoeia [22]. The test solution was
prepared by adding 10 tablets of OLP into a volumetric
flask, appropriate volume of acetonitrile was used to dis-
solve it. The mixture was then diluted with 0.01 M HCl to
make a final concentration of 0.01% (w/v) OLP. A 10 mg
quantity of olanzapine reference solution was dissolved
in about 25 mL of acetonitrile and diluted to 100 mL with
0.01 M HCl in a volumetric flask. The content of olanza-
pine was calculated. Olanzapine tablets contain not less
than 90.0 and not more than 110.0% of the stated amount
of olanzapine.
3.  Results  and  discussion
Olanzapine formed an immediate purple colour with
chloranilic acid and the colour became more intense
with time. This is an evidence of the formation of a
charger-transfer (CT) complex. Chloranilic acid is a
well known -acceptor and the OLP containing amino
functional groups serve as n-donors. Chloranilic acid
has been used for the spectrophotometric determination
of drugs containing n-electron donors such as nitro-
gen and oxygen. This molecular complex consists of
constituents held together by weak secondary valence
forces of the donor-acceptor type or hydrogen bonds.
This secondary valence force is not a clearly defined
bond but rather as an overall attraction between two
aromatic molecules. Important factor in the formation
of molecular complexes by this compound is presence
of steric factors which hinders this process [23]. These
complexes (electron donor–acceptor complexes) may be
formed when an electron donor group is adjacent to an
electron acceptor group. In this situation, experimental
evidences suggest that the donor may transfer a por-
tion of its charge to the acceptor. Thus, one compound
becomes partially positively charged with respect to the
other and a weak electrostatic bond is formed. Bond
formation between molecular pairs is brought about
when filled orbitals or non-bonding orbitals in the donor
molecule overlap with the depleted orbitals in the accep-
tor molecule.
O.A. Adegoke et al. / Journal of Taibah University for Science 10 (2016) 651–663 655
Table 1
Rf values for reversed phase thin layer chromatographic analysis.
Mobile phase systems OLP OLP–CAA Complex CAA
Acetonitrile:Water (6:4) 0.53 0.49 0.70
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eethanol:Water (6:4) 0.16 0.12 0.86
LP, olanzapine; CAA, chloranilic acid.
Further evidence for the formation of a new molec-
lar entity from the reaction between OLP and CAA
apart from the spot tests) is the TLC analysis of the
eaction mixture compared with OLP and CAA alone.
he results are presented in Table 1. Using reversed
hase TLC mode, clearly defined spots were obtained
or the three species. Using acetonitrile and methanol
s the organic modifier, OLP–CAA molecular adduct
ad the least polarity compared to OLP and CAA alone.
ne other clear peculiarity observed for the reaction is
he formation of single spot for the CT complex show-
ng that one mole of the drug combined with a mole of
AA. The reversed phase TLC proved more effective
t studying these reaction species because of the highly
olar nature of OLP. On forming the complex with CAA
he OLP–CAA adduct had the least polarity confirming
he formation of a new molecular entity held together by
eak secondary binding forces.
The absorption spectra of chloranilic acid and the
harge-transfer complex produced with the OLP are pre-
ented overlaid with that of OLP in Fig. 2. The major
bsorption of olanzapine is around 250 nm (λmax) while
AA exhibits prominent peaks at 310 and 430 nm. How-
ver on reaction of CAA with OLP a new prominent
0
0.4
0.8
1.2
1.6
2
250 35 0 45 0 550 650 750
Wavelength (nm)
A
bs
or
ba
nc
e
OLP
CAA
Complex
ig. 2. Absorption of spectra of the charge-transfer complexation
etween olanzapine and chloranilic acid overlaid on chloranilic acid.Fig. 3. Optimization of temperature for the charge-transfer complex-
ation between OLP and CAA.
low-energy absorption band was formed at 520 nm. This
provides clear evidence for the formation of a new
molecular entity. Therefore, 520 nm was selected as the
working wavelength and affords the determination of the
drug in the visible region to avoid non-specific absorp-
tion in the UV region. The reaction occurring leading
to the formation of the new CT band is presented in
Scheme 1. The formation of a radical anion in such
molecular interactions has been established by electron-
spin resonance measurements [24]. The formation of a
new absorption peak at 520 nm represents significant
bathochromic shift relative to the absorption bands of
both CAA and OLP. Olanzapine contains a secondary
amine site in the diazepine ring and charge-transfer
donors have been recognized to be predominantly pri-
mary or secondary amino groups in addition to oxygen
derivatives. The avidity of formation of the new CT
complex may be due to increased stabilization of the
charge transfer by the extensive chromophoric systems
in olanzapine.
3.1.  Optimization  studies
Two key factors that can affect the rate and extent of
formation of the charge-transfer complex were identi-
fied as temperature and time. These two factors were
studied and optimized. The optimization of tempera-
ture for the formation of the CT complex between CAA
and OLP is presented in Fig. 3. Two time levels were
studied at temperatures of 30, 50, 60 and 80 ◦C. Using
5 and 20 min reaction time periods; CAA was found
to optimally combine with OLP at room temperature
in both instances. There was a gradual decline in the
absorptivity of the molecular complex as the temper-
ature increased from 30 to 80 ◦C. This decrease was
656 O.A. Adegoke et al. / Journal of Taibah University for Science 10 (2016) 651–663
plexatiScheme 1. Formation of charge-transfer com
found to be more apparent at 20 min reaction time. This
decrease in absorptivity was characterized by the gradual
discharge of the purple colours produced with CAA at
elevated temperatures with increasing incubation times.
This dis-stabilization of molecular charge transfer is typ-
ical of most CT complexes as increase in temperature
destroys the intermolecular binding forces of attraction
between ion pairs. It is often observed that since weak
intermolecular secondary binding forces are responsible
for the formation of a CT band, then increase in temper-
ature can lead to distortion of such binding interactions.on between olanzapine and chloranilic acid.
Thus, 30 ◦C was selected as the optimum time required
for the formation of the CT complex between CAA
and OLP. In some of our previous utilization of
CAA as charge-transfer acceptor, room temperature
analyses have been afforded and elevated tempera-
tures were observed to destroy the formed complexes
[25–28].The effect of time allowed for reaction between OLP
and CAA at 30 ◦C was monitored at time levels ranging
from 0 to 30 min. The results are presented in Fig. 4.
From the results obtained, the absorbance value for the
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Y = 0.00514X  + 0.05793 with a correlation coefficient
of 0.9977. The slope and intercept of the calibration
lines gave small 95% confidence limits thus adjudging
Table 2
Analytical and validation parameters for the CT complexes of OLP
with CAA.
Parameter Olanzapine (OLP)
Beer’s law limits (g mL−1) 2–40
Limit of detection (g mL−1) 1.57
Limit of quantitation (g mL−1) 4.77
Molar absorptivity (L mol−1 cm−1) (2.302 ± 0.262) × 103
Sandell’s sensitivity (g mL−1 per
0.001 absorbance unit)
0.195
Regression equationa
Intercept ± 95%CI 0.05793 ± 0.20 × 10−2
Slope ± 95%CI 0.00514 ± 0.31 × 10−2
Correlation coefficient, r 0.9977
Formation constantb, K 6.279 × 109ig. 4. Effect of time of reaction on complex formation at 30 ◦C.
omplex increased steadily from 0 min to a peak at
0 min. Thereafter, further incubation beyond 10 min led
o a gradual decline in the absorbance value. Thus, 30 ◦C
nd 10 min reaction conditions were selected as optimal
onditions for the charge-transfer complexation reaction
etween OLP and CAA. A critical look at the effect of
ime presented in Fig. 4 shows that only a slight reduc-
ion in the absorbance of the CT complex was obtained
eyond 10 min (2.08% decrease). This thus suggests the
uitability and stability of the analytical system for the
ssay of OLP by this CAA method.
The concentration of CAA used as reagent in this
tudy as well as the adoption of acetonitrile as dilut-
ng solvent stems from other previous experiences and
pplications with the utilization of CAA [25–28].
Following the optimization of the temperature and
ime required for the analysis of OLP by the CAA
ethod, the stoichiometric ratio at which the two reac-
ants were combining was investigated using Job’s
ethod of continuous variation [29]. The results
btained for the stoichiometric ratio assessment is pre-
ented in Fig. 5. For interacting species at a constant
otal concentration, the complex (adduct) is at its greatest
oncentration at a point where the species are com-
ined in the ratio in which they occur in the complex
30]. The plot of absorbance against the mole frac-
ion of the reagent exhibited a change of slope with
 maximum absorbance at a mole fraction of 0.5 and
ecreasing absorbance as the value of the mole fraction
eviates from 0.5. The implication of this observation
s that combining equal volumes of equimolar con-
entrations of the reagent and drug stock solution will
roduce the highest possible absorbance reading. It also
ignifies that the OLP and CAA reagent react in aFig. 5. Stoichiometric ratio determination for the reaction between
CAA and OLP.
1:1 stoichiometric ratio under the optimal conditions
routinely used for the charge-transfer complexation reac-
tion.
3.2.  Validation  studies
Calibration curves were prepared using the opti-
mized procedures and the results of the analytical and
validation parameters are presented in Table 2 for the
OLP–CAA molecular complex. Excellent calibration
data were obtained for the average determinations of
the calibration curves constructed on each of three suc-
cessive days. The linear regression line equation isa Y = bX + a, where Y is the absorbance for concentration X g mL−1.
b Estimated from Benesi-Hildebrand plot.
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Table 3
Intra-day and inter-day accuracy and precision of the charge-transfer complexation method.
Assessment Amount taken (g mL−1) Amount found (g mL−1) Recovery (%) RSD (%)c Relative error (%)
Intra-daya 5 5.048 100.96 0.83 0.96
15 15.140 100.94 0.32 0.93
30 30.267 100.89 0.32 0.89
Inter-dayb 5 5.049 100.98 1.12 0.98
15 15.124 100.83 0.48 0.83
30 30.380 101.26 0.41 1.27
a Average of six determinations.
b Average of 12 determination.
c RSD, relative standard deviation.
the suitability of the procedure to detect small changes
in the concentration of olanzapine. The Beer’s law
range is 2–40 g mL−1 and a molar absorptivity of the
range 2.302 ±  0.262 ×  103. The sensitivity of the pro-
cedure was assessed using Sandell’s sensitivity and it
was found to be 0.195 g mL−1 per 0.001 absorbance
unit.
The limit of detection (LOD) and limit of quanti-
tation (LOQ) were estimated according to the current
ICH guidelines using the expressions 3.3σ/S  and 10σ/S,
respectively where, σ is the standard deviation of the
absorbance of blank (n  = 6) and S  is the slope of the cali-
bration line. The LOD and LOQ were respectively found
to be 1.57 and 4.77 g mL−1. These low limits were
found to compare favourably with previously reported
methods for olanzapine.
Using the optimized systems and calibration curves,
the recovery studies of OLP from quality control sam-
ples were carried out for accuracy and precision of a
three-day assessment period. The results of the 3-day
assessment are presented in Table 3. For the intra-day
assessment, accuracy (estimated by % relative errors)
were generally less than 1% for the three concentration
levels of 5, 15 and 30 representing the low, mid and
high concentration point on the calibration plot as rec-
ommended by the ICH. The intra-day precision using %
relative standard deviation gave values also far less than
1%. From the assessment, it was discovered that both
the precision and accuracy were better for higher con-
centrations than the lowest concentration level. This is
expected, as it is a lot easier to handle the larger con-
centration volumes. Table 3 also contains the results
of the inter-day assessments of accuracy and precision
at the concentration levels adopted for the intra-day
assessments. In all instances, low inaccuracies and low
% RSD were obtained. These results once again jus-
tify the suitability of the CAA system for the assay of
olanzapine.3.3.  Estimation  of  molar  absorptivity  and  formation
constants
The absorbance values obtained in the calibration
curve plot were plotted as a function of ratio of the molar
concentration of the donor:acceptor ([D]0:[A]0) accord-
ing to the Benesi-Hildebrand equation [21] using the
expression in Eq. (1).
( [A]0
A
= 1
KCTεCT
.
1
[D]0
+ 1
εCT
)
(1)
where [A]0 is the initial concentration of the accep-
tor (CAA), A is the absorbance of the charge-transfer
band, [D]0 is the initial concentration of the donor
(olanzapine), KCT is the formation constant of the new
charge-transfer band and εCT is the molar absorptivity.
A plot of [A]0/A against 1/[D]0 will yield intercept as
1/ε and the slope as 1/K  ε  from where the formation
constant and the molar absorptivity are obtained. The
concentration of the acceptor was kept greater than the
donor and fixed so that a wide concentration range could
be adopted. The Benesi-Hildebrand plot is presented in
Fig. 6. Relatively higher molar absorptivities and forma-
tion constants were observed for the studied complexes
at room temperature relative to the values determined
at higher temperature levels. Marginal differences were
however observed for these parameters at temperatures
of 50, 60 and 80 ◦C, with a gradual decline in the param-
eters were obtained. Although the molar absorptivities
are supposed to be independent of temperature, empiri-
cally this has been found not to hold true. This is because
increase in temperature has been found to affect molec-
ular complexes. Since the formation of a charge-transfer
complex is an association of some type, and probably an
association existing in equilibrium, any factor that will
promote dissociation of the complex will lead to reduced
absorptivity.
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Mig. 6. Benesi-Hildebrand plot for the charge-transfer complexation.
Temperature is one of such factors that can lead to
reakdown of the formed complex especially if such
ormation is associated with an exothermic change and
his will lead to the equilibrium shifting towards the
ree donor and acceptor species which do not have
ignificant absorbance values at the 520 nm used as
nalytical wavelength [26]. These observations are par-
icularly evident for the current case at hand as the
bsorption spectra showed no significant absorptivities
or the free OLP and CAA at 520 nm. And in addi-
ion, the optimization of coupling reaction temperature
evealed that increasing the temperatures from 30 to
0 ◦C also produced decreasing absorptivities. Since
stimation of both the molar absorptivities and forma-
ion constants depend on the absorbance values, the
rend observed in Table 4 is anticipated. Thus expectedly,
he complexes were determined at room temperature.
his study involving estimation of molar absorptivities
nd formation constants as a function of temperature
urther lends credence to the understanding that molec-
lar associations are affected by diverse properties of
eactants and reaction conditions such as concentra-
ion, chemical structure, temperature and time. The
LP–CAA system described in this work provides alear model for the study of the influence of these
actors.
able 4
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3.4.  Physicochemical  parameters  for  the  formation
of CT-complex
In order to characterize the complex formed between
olanzapine and the charge acceptor molecule, CAA;
some physicochemical parameters were estimated to
explain the propensity or otherwise of the formation of
the intermolecular charge-transfer complex. The various
physicochemical parameters obtained are summarized in
Table 4.
The first physicochemical parameter calculated was
the transition energy of the complex which is obtained
from the expression hνCT where h  is Planck’s constant
and νCT is the wavenumber of the absorption peak of
the CT complex. The transition energy was found to be
2.303 eV.
Two other physicochemical parameters estimated
were oscillator strength and transition dipole moment.
The oscillator strength (f) is a dimensionless quantity
used to express the transition probability of the CT band
and the transition dipole moment (μEN) of the CT com-
plex [30]. Both parameters are obtained from Eqs. (2)
and (3), respectively.
f  =  4.32 × 10−9[εΔv1/2] (2)
μ
EN=0.095
[
εCTΔv1/2
Δv
]1/2 (3)
where ν1/2 is the half-width, i.e. the width of
the band at the half the maximum absorption, and
ν ≈  wavenumber at the absorption maximum. The
oscillator strength, f and the transition dipole moment
obtained are 7.289 and 0.892 Debye, respectively.
The ionization potential, ID, of the donor in the
charge-transfer complex was another physicochemi-
cal parameter calculated using the empirical equation
derived by Aloisi and Pigantro in 1973 [31] (presented
in equation 4).
−4where νCT is the wavenumber of the CT band in cm−1.
ID was found to be 6.054 eV.
apine and chloranilic acid.
μEN (Debye) RN (eV) ID (eV) W (eV)
0.892 4.687 6.054 2.651
h University for Science 10 (2016) 651–663
y = 45.974x + 10.127
R² = 0.9611
10.255
10.2 6
10.265
10.2 7
10.27 5
10.28
10.28 5
0.0028 0.0029 0.003 0.0031 0.0032 0.0033 0.0034
Lo
g 
K
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The resonance energy of the complex (RN) in the
ground state is obtained from the theoretical equation
derived by Brieglieb [32] given in Eq. (5).
εCT =  7.7 ×  104/[hνCT ]/RN −  3.5 (5)
where εCT is the molar absorptivity of the complex at
the maximum of the CT absorption, hνCT is the transi-
tion energy of the complex. The resonance energy was
calculated as 4.687 eV for the new molecular complex.
The dissociation energy (W) of the formed CT com-
plex between OLP and CAA was calculated from the
transition energy (hνCT), ionization potential of the
donor (ID) and the electron affinity of CAA (EA = 1.1)
using the relationship in Eq. (6) [33].
hvCT =  ID −  EA −  W (6)
The dissociation energy was found to be 2.651 eV.
From the results presented in Table 4, some
observable trends are clearly evident from these phys-
icochemical parameters. The values obtained points to
the good stability of the complex formed between CAA
as acceptor and olanzapine as donor. The ionization
potential of the donor gave a high value of 6.054 eV
denoting that OLP is a good n-electron donor and mak-
ing the electrons readily available for donation to an
acceptor such as CAA. This is not surprising as nitro-
gen atom whether as a primary, secondary or tertiary
amino group happen to be one of the best electron donors
in charge-transfer complexation reactions and most of
the previously reported procedures involving CAA have
been successfully carried out when the donor functional
group contains nitrogen. The secondary amino group
found in olanzapine has proven to be a useful electron
donor from the results of the ID obtained. The transi-
tion energy is about two times less than this ionization
energy of OLP, hence, the energy barrier required for
electronic transition is readily surmounted and the com-
plex is produced readily. This further confirms the avidity
at which the complex was produced. The dissociation
energy (W) was also found to be far less than ID. Thus
the spontaneous decomposition of the CT complex will
be minimal especially at room temperature where these
values were obtained from. This is further confirmed by
the fact that gradual decomposition of the complex was
only observed at elevated temperatures. The high res-
onance energy of the formed complex will produce a
stabilization effect on the complex and this is expected
considering the bulky nature of OLP and the tendency to
be stable upon donation of a lone pair electron to CAA.
The estimation of these physiochemical parameters
has given a good clue to the relative stability of theFig. 7. Plot of log K of OLP–CAA complexes as a function of 1/T
(K−1).
intermolecular complex formed between olanzapine and
CAA at room temperature.
3.5.  Thermodynamic  considerations  of  the
charge-transfer  complexation  reaction
The thermodynamic functions, standard free energy
change (G◦) the enthalpy change (H)  and the entropy
change (S) were obtained from the well established
Eqs. (7)–(9), respectively.
−ΔG◦ =  2.303RT log KCT (7)
log K  =  − ΔH
2.303
(
1
T
)
+  Constant (8)
−ΔG◦ =  ΔH  −  T ΔS  (9)
The enthalpy of the CT formation was obtained by
plotting the log of formation constant against the recip-
rocal of absolute temperature. The plot is presented
in Fig. 7. Table 5 contains the various thermodynamic
parameters obtained, alongside the molar absorptivities
and formation constants at the four temperature levels.
The standard free energy gave a negative value at all the
four temperature conditions considered in this experi-
mental design. This result points to the exothermic nature
of the complex formation. This thus explains why higher
temperature values led to decrease in the absorbance of
the complex. The Gibbs free energy became increas-
ingly higher with increase in temperature denoting that
it becomes difficult to generate the complex at higher
temperatures. Since it is established that the formation
of the complex occurs through an exothermic process,
higher temperature will prevent the avidity of reaction
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Table 5
Thermodynamic changes following complexation between olanzapine and chloranilic acid.
Temperature (K) Molar absorptivity, ε
(L mol−1 cm−1)
Formation constant, K
(M−1)
ΔG◦
(kJ mol−1)
ΔH (kJ mol−1) ΔS (kJ mol−1)
303 1.687 × 103 1.9014 × 1010 −59.635 0.1997
323 1.656 × 103 1.8661 × 1010 −63.521 −0.8803 0.1994
333 1.625 × 103 1.8310 × 1010 −65.435 0.1991
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G◦ is the free energy change, H is the enthalpy change and S is 
nd the spontaneity of the charge-transfer complexation.
he high Gibbs free energy obtained even at room tem-
erature however attests to the ease of formation of the
omplex. Though relatively small, the enthalpy change
lso points to the possibilities of ease of formation of the
T complexes. The enthalpy of formation for the molec-
lar complex was found to be −0.8803 kJ mol−1. The
ntropy also gave relatively high values with the value
educing as temperature increased. A gradual decline
n the entropy with temperature increase was observed
or the formation of intermolecular charge-transfer com-
lexation. This implies a lower degree of randomness as
 function of temperature and lower tendencies of form-
ng stable complexes. All the thermodynamic parameters
stimated however suggest that the complexes are rel-
tively stable at room temperature compared to the
levated temperatures.
.6.  Proposed  reaction  mechanism
The proposed reaction mechanism is presented in
cheme 1. In this study, the chloranilic acid molecule
n the reaction mixture induces its own delocalization of
lectrons due to dipole moment that exist between the
arbon and oxygen atoms of the carbonyl group in the
olecule of chloranilic acid (C O; Cð+ Oð−), [step a].
lso in the reaction mixture, the lone pair of the elec-
rons on the nitrogen atoms of the amine group in the
lanzapine molecule (H2N:) are available for the chlo-
anilic molecule (electron deficient) [step b], resulting
able 6
omparative dosage form analysis using the new method and official HPLC m
rug
ormulation
New methoda HPLC methoda
Amount found (g) % RSD Amount found (g) % R
anzep 10® 20.93 0.46 20.70 1.45
lenmark® 20.44 2.85 20.60 1.94
lanza 10® 20.87 0.37 20.71 1.40
a Mean value, n = 6. Content of OLP stated by Indian Pharmacopoeia range
b % recovery calculated as a ratio of the new method to the official method.
c Statistical analyses done between the results obtained from the proposed m−69.369 0.1990
opy change.
in the formation of complex [step c]. Such reactions are
usually avidly possible in solvents that promote electron
transfers as acetonitrile and 1,4-dioxan.
Since the formation of this complex involves elec-
tronic transition from olanzapine an electron rich
molecule (Lewis-base donor) to an electron deficient
(chloranilic acid) molecule (Lewis-acid acceptor), they
are called charge-transfer complexes. The bond forma-
tion between the molecular pairs is brought about when
non-bonding orbital in the donor, olanzapine overlaps
with the depleted orbital in the acceptor chloranilic acid.
The lower energy molecular orbital (MO) for the com-
plex is occupied in the ground state, and transitions from
this molecular orbital (MO) in the ground state to new
absorption bands.
3.7.  Dosage  form  analysis
The new procedure was adopted for the estimation of
the content of OLP in three commonly available tablet
brands in Ibadan metropolis where this study was con-
ducted. The results obtained (using the CAA method)
were compared with those obtained using the official
Indian Pharmacopoeial method. The results for the com-
parative dosage form analysis using the new method and
official HPLC method are presented in Table 6. All the
three brands analyzed passed and there were no signifi-
cant differences in the content of OLP in the tablet brands
when assessed by the new method and the official HPLC
method. This shows that both methods are equivalent.
ethod.
Mean recovery ± S.D.
(%)b
Error (%) Statistics (p values)c
SD F-ratio test t test
 101.10 ± 0.47 1.10 0.05 0.59
 99.23 ± 2.83 0.77 0.83 0.77
 100.77 ± 0.38 0.77 0.05 0.68
s from 90% to 110%.
ethod and the official method.
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3.8.  Comparative  advantages  of  the  new
charge-transfer  methodology
One clear-cut advantage of the new charge-transfer
method developed and validated for the assay of olanza-
pine using chloranilic acid as described in this work is the
single step involved in the adoption of the method. Many
of the previously reported spectrophotometric tech-
niques utilize multistep procedures with the attendant
compromise of accuracy. In addition the new method is
simple, accurate and precise and utilized well known and
readily available reagents. It is also a room temperature
analysis and can be utilized without stringent control
of many environmental factors. It is the first reported
of such charge-transfer reactions and holds promise of
adaptation in any analytical setting.
4.  Conclusion
A new colorimetric method for the assessment and
quality control of olanzapine in bulk and dosage forms
has been successfully developed. The method holds
promise as a simple, fast and accurate technique for the
in-process and post-marketing surveillance of the drug
especially judging from the standpoint of the variety of
generic brands of olanzapine currently available in the
market.
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